Work

Abstract 3066: Fumarylacetoacetate hydrolase (FAH) stimulates resistance to CDK4/6 inhibitors in hormone receptor-positive breast cancer via a novel non-canonical function

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-3066

Authors: Jenny Hogstrom, Boryana Petrova, Hanna Doh, Camila Perea, Su Min Hong, Nina Kozlova, Kayla Cruz, Conor L. Evans, Jonah Lee, John Clohessy, Gerburg Wulf, Laura Collins, Naama Kanarek, Taru Muranen

Institutions: Beth Israel Deaconess Medical Center, Boston Children's Hospital, Massachusetts General Hospital

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409689934

Cites:

Cited by:

Related to: 10